Potassium chloride transporter activator - OMass Therapeutics
Alternative Names: KCC2 activator; KCC2/SLC12A5 activator; Potassium chloride transporter, solute carrier family 12 member 5 - OMass Therapeutics; SLC12A5 activatorLatest Information Update: 11 Nov 2021
At a glance
- Originator OMass Therapeutics
- Class Antiepileptic drugs; Small molecules
- Mechanism of Action Potassium channel agonists; Solute carrier protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Epilepsy